Geriatric Study Incentives Modeled On Pediatric Patent Extensions Suggested

Incentives for pharmaceutical companies to conduct Phase IIIb studies to identify problems among drugs used frequently by elderly patients is recommended in a report released at a press briefing by the Alliance for Aging Research June 9.